Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...

That comforting morning cup of coffee is more than just a wake-up call; it's a complex brew that interacts with your body at ...

Breakthrough Mouse Study Hints At Psychedelic Compound Yielding Possible Anti-Aging Drugs In A Nutshell Lab studies found ...

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...

ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.

A better understanding of human smell is emerging as scientists interrogate its fundamental elements: the odor molecules that ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...